Wave Life Sciences

Wave Life Sciences (NASDAQ: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aims to use PRISM (the company’s proprietary discovery and drug development platform) to develop best-in-class drugs across multiple therapeutic modalities, enabling the precise design, optimization, and production of stereopure oligonucleotides. Driven by a steadfast sense of urgency, the Wave team targets a broad range of genetic diseases to help patients and families achieve a brighter future.